Product
Shz QIV
1 clinical trial
1 indication
Indication
InfluenzaClinical trial
Safety of a Single Dose (Participants Aged 9 Years and Older) or Two Doses Given 28 Days Apart (Participants Aged 6 Months to 8 Years) of the Shenzhen Quadrivalent Influenza Vaccine (Split Virion), InactivatedStatus: Completed, Estimated PCD: 2019-06-06